These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2878729)

  • 1. Safety: cimetidine and concomitant theophylline or warfarin--drug interactions and their implications.
    Frank WO
    Clin Ther; 1986; 8 Suppl A():57-68. PubMed ID: 2878729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of two cimetidine regimens on 24-hour intragastric acidity in patients with asymptomatic duodenal ulcer.
    Mahachai V; Walker K; Jamali F; Navert H; Cook D; Symes A; Thomson AB
    Clin Ther; 1984; 6(3):259-81. PubMed ID: 6373006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of theophylline and the H2-antagonist drugs cimetidine and ranitidine.
    Dal Negro R; Pomari C; Zoccatelli O; Trevisan F; Carloni C; Turco P
    Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):221-6. PubMed ID: 6325354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clopidogrel does not affect the pharmacokinetics of theophylline.
    Caplain H; Thebault JJ; Necciari J
    Semin Thromb Hemost; 1999; 25 Suppl 2():65-8. PubMed ID: 10440427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H2-antagonist derangement of the kinetics of sustained-release oral theophylline.
    Dal Negro R; Turco P; Zoccatelli O; Trevisan F; Pomart C
    Int J Clin Pharmacol Ther Toxicol; 1985 Jun; 23(6):329-32. PubMed ID: 2862112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of low-dose cimetidine on theophylline metabolism.
    DeAngelis C; Walker SE; Bartle WR
    Clin Pharm; 1983; 2(6):563-7. PubMed ID: 6653057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisoprolol: studies of potential interactions with theophylline and warfarin in healthy volunteers.
    Warrington SJ; Johnston A; Lewis Y; Murphy M
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S164-8. PubMed ID: 11527121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of morning or evening administration on absorption of theophylline.
    Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cimetidine-theophylline interaction: effects of age and cimetidine dose.
    Cohen IA; Johnson CE; Berardi RR; Hyneck ML; Achem SR
    Ther Drug Monit; 1985; 7(4):426-34. PubMed ID: 4082242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cimetidine and ranitidine on the pharmacokinetics of a chronotherapeutically formulated once-daily theophylline preparation (Uniphyl).
    Fraser IM; Buttoo KM; Walker SE; Stewart JH; Babul N
    Clin Ther; 1993; 15(2):383-93. PubMed ID: 8519046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of cimetidine on the pharmacokinetics of theophylline.
    Schwartz JI; Bachmann KA; Bond LW; Mahajan VK
    Clin Pharm; 1982; 1(6):534-8. PubMed ID: 7185539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of theophylline clearance by cimetidine but not ranitidine.
    Powell JR; Rogers JF; Wargin WA; Cross RE; Eshelman FN
    Arch Intern Med; 1984 Mar; 144(3):484-6. PubMed ID: 6322709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celecoxib does not significantly alter the pharmacokinetics or hypoprothrombinemic effect of warfarin in healthy subjects.
    Karim A; Tolbert D; Piergies A; Hubbard RC; Harper K; Wallemark CB; Slater M; Geis GS
    J Clin Pharmacol; 2000 Jun; 40(6):655-63. PubMed ID: 10868317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in the plasma clearance rate of warfarin induced by cimetidine.
    Bell WR; Anderson KC; Noe DA; Silver BA
    Arch Intern Med; 1986 Dec; 146(12):2325-8. PubMed ID: 3778066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of theophylline during co-treatment with cefaclor.
    Jonkman JH; van der Boon WJ; Schoenmaker R; Holtkamp A; Hempenius J
    Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):88-92. PubMed ID: 3957498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Night-time pharmacokinetics of once a day theophylline: a steady state comparison of three preparations.
    Karttunen P; Tukiainen H; Nykänen S; Saano V
    Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):161-5. PubMed ID: 3997302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.